Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Haanen

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|December 1, 1996
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infectionJ B Haanen, R Bieger, J W van't Wout
The Journal of Experimental Medicine|November 2, 1999
Selective expansion of cross-reactive CD8(+) memory T cells by viral variantsJ B Haanen, M C Wolkers, A M Kruisbeek, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 2004
[Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency]E A Hooiveld, A B van Kuilenburg, J B Haanen, et al.
European Journal of Immunology|May 6, 1999
Systemic T cell expansion during localized viral infectionJ B Haanen, M Toebes, T A Cordaro, et al.
Human Immunology|December 1, 1995
Clonal dominance and selection for similar complementarity determining region 3 motifs among T lymphocytes responding to the HLA-DR3-associated Mycobacterium leprae heat shock protein 65-kd peptide 3-13L Struyk, G E Hawes, J B Haanen, et al.
European Journal of Immunology|May 23, 2000
Tracing and characterization of the low-avidity self-specific T cell repertoireK E de Visser, T A Cordaro, D Kioussis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2016
(Neo)adjuvant systemic therapy for melanomaM C T van Zeijl, A J van den Eertwegh, J B Haanen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Targeted treatment and immunotherapy in leptomeningeal metastases from melanomaM H Geukes Foppen, D Brandsma, C U Blank, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1991
Natural killer cell clones can efficiently process and present protein antigensM G Roncarolo, M Bigler, J B Haanen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2015
Vemurafenib for BRAF V600 mutated advanced melanoma: results of treatment beyond progressionA Scholtens, M H Geukes Foppen, C U Blank, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|December 1, 1996
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infectionJ B Haanen, R Bieger, J W van't Wout
The Journal of Experimental Medicine|November 2, 1999
Selective expansion of cross-reactive CD8(+) memory T cells by viral variantsJ B Haanen, M C Wolkers, A M Kruisbeek, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 2004
[Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency]E A Hooiveld, A B van Kuilenburg, J B Haanen, et al.
European Journal of Immunology|May 6, 1999
Systemic T cell expansion during localized viral infectionJ B Haanen, M Toebes, T A Cordaro, et al.
Human Immunology|December 1, 1995
Clonal dominance and selection for similar complementarity determining region 3 motifs among T lymphocytes responding to the HLA-DR3-associated Mycobacterium leprae heat shock protein 65-kd peptide 3-13L Struyk, G E Hawes, J B Haanen, et al.
European Journal of Immunology|May 23, 2000
Tracing and characterization of the low-avidity self-specific T cell repertoireK E de Visser, T A Cordaro, D Kioussis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2016
(Neo)adjuvant systemic therapy for melanomaM C T van Zeijl, A J van den Eertwegh, J B Haanen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Targeted treatment and immunotherapy in leptomeningeal metastases from melanomaM H Geukes Foppen, D Brandsma, C U Blank, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1991
Natural killer cell clones can efficiently process and present protein antigensM G Roncarolo, M Bigler, J B Haanen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2015
Vemurafenib for BRAF V600 mutated advanced melanoma: results of treatment beyond progressionA Scholtens, M H Geukes Foppen, C U Blank, et al.
Pageof 3